Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06892379 · ClinicalTrials.gov registry record · Phase 1

A Study of HS-20110 in Participants With Advanced Solid Tumors

A Phase 1 study of Solid Tumors, sponsored by Hansoh BioMedical R&D Company.

Recruiting
Registry status
Phase 1
Development phase
475
Enrollment target
6
Study locations

NCT06892379 is a Phase 1 study of Solid Tumors that is actively recruiting participants, run by Hansoh BioMedical R&D Company. The registered enrollment target is 475 participants, above the 281-participant average among 125 other Solid Tumors trials with a reported enrollment target (69% higher). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06892379, a Phase 1 study of Solid Tumors, is actively recruiting participants, sponsored by Hansoh BioMedical R&D Company.

RECRUITING
Registry status
Phase 1
Development phase
475 participants
Enrollment target
6
Study locations

Study Summary

This is an open-label, multicenter study to evaluate the safety and tolerability of HS-20110 in participants with advanced solid malignant tumors

Conditions Studied

Solid Tumors

Interventions

  • DRUG HS-20110 (Phase Ia：Dose escalation )
  • DRUG HS-20110 (Phase Ib:Dose expansion )

Study Locations (6)

Texas

  • The University of Texas MD Anderson Cancer Center - Houston
  • NEXT Dallas - Irving
  • NEXT Oncology - San Antonio

Florida

  • BRCR Medical Center INC - Tamarac

Virginia

  • NEXT Virginia - Fairfax

Guangdong

  • SUN YAT-SEN University Cancer Center - Guangzhou

Trial Details

FieldValue
Enrollment Target 475 participants
Start Date 2025-02-26
Est. Completion 2027-09-30
Phase Phase 1

Sponsor

Hansoh BioMedical R&D Company

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06892379

The ClinicalTrials.gov registry entry for NCT06892379 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 475 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 281-participant average among 125 other Solid Tumors trials with a reported enrollment target (69% higher). The listed sponsor is Hansoh BioMedical R&D Company, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 2 interventions - of which HS-20110 (Phase Ia：Dose escalation ) is the first listed.

NCT06892379 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Texas, Florida, Virginia.

Frequently Asked Questions

What is clinical trial NCT06892379 about?

NCT06892379 is a clinical study titled "A Study of HS-20110 in Participants With Advanced Solid Tumors". This is an open-label, multicenter study to evaluate the safety and tolerability of HS-20110 in participants with advanced solid malignant tumors

What is the current status of trial NCT06892379?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 475 participants. The study started on 2025-02-26. Estimated completion is 2027-09-30.

What conditions does trial NCT06892379 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT06892379?

The interventions under investigation include: HS-20110 (Phase Ia：Dose escalation ) (DRUG), HS-20110 (Phase Ib:Dose expansion ) (DRUG).

Who is sponsoring clinical trial NCT06892379?

This trial is sponsored by Hansoh BioMedical R&D Company, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06892379 being conducted?

This trial has 6 study locations across Florida, Texas, Virginia, Guangdong. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.